The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8 + T-cell responses in vitro.

MLA

Papagno, Laura, et al. “The TLR9 Ligand CpG ODN 2006 Is a Poor Adjuvant for the Induction of de Novo CD8 + T-Cell Responses in Vitro.” Scientific Reports, vol. 10, no. 1, July 2020, p. 11620. EBSCOhost, https://doi.org/10.1038/s41598-020-67704-0.

APA

Papagno, L., Kuse, N., Lissina, A., Gostick, E., Price, D. A., Appay, V., & Nicoli, F. (2020). The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8 + T-cell responses in vitro. Scientific Reports, 10(1), 11620. https://doi.org/10.1038/s41598-020-67704-0

Chicago

Papagno, Laura, Nozomi Kuse, Anna Lissina, Emma Gostick, David A Price, Victor Appay, and Francesco Nicoli. 2020. “The TLR9 Ligand CpG ODN 2006 Is a Poor Adjuvant for the Induction of de Novo CD8 + T-Cell Responses in Vitro.” Scientific Reports 10 (1): 11620. doi:10.1038/s41598-020-67704-0.